169 related articles for article (PubMed ID: 2411806)
21. Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells.
Kojima M; Cease KB; Buckenmeyer GK; Berzofsky JA
J Exp Med; 1988 Mar; 167(3):1100-13. PubMed ID: 2450949
[TBL] [Abstract][Full Text] [Related]
22. T cell responses to Mls determinants are restricted by cross-reactive MHC determinants.
Lynch DH; Gress RE; Needleman BW; Rosenberg SA; Hodes RJ
J Immunol; 1985 Apr; 134(4):2071-8. PubMed ID: 2579127
[TBL] [Abstract][Full Text] [Related]
23. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
24. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
25. Assessment of antigen-specific restriction sites on Ia molecules as defined by the bm12 mutation.
Kanamori S; Walsh WD; Hansen TH; Tse HY
J Immunol; 1984 Dec; 133(6):2811-4. PubMed ID: 6208261
[TBL] [Abstract][Full Text] [Related]
26. T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.
Abe R; Hodes RJ
J Immunol; 1988 Jun; 140(12):4132-8. PubMed ID: 2453568
[TBL] [Abstract][Full Text] [Related]
27. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
28. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
Janeway CA; Katz ME
J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
[TBL] [Abstract][Full Text] [Related]
29. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
30. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
31. An analysis of functional T cell recognition sites on I-E molecules.
Needleman BW; Pierres M; Devaux CA; Dwyer PN; Finnegan A; Sachs DH; Hodes RJ
J Immunol; 1984 Aug; 133(2):589-96. PubMed ID: 6203968
[TBL] [Abstract][Full Text] [Related]
32. Delineation of Ia:nominal antigen complementary determinants recognized by T cells in studies of gene complementation in response to insulin.
Lin CC; Hansen TH; Passmore HC; Rosenthal AS; Tse HY; Walsh WD; Kanamori S
J Immunol; 1984 Jan; 132(1):303-9. PubMed ID: 6197448
[TBL] [Abstract][Full Text] [Related]
33. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H
J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859
[TBL] [Abstract][Full Text] [Related]
34. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules.
Ashwell JD; Chen C; Schwartz RH
J Immunol; 1986 Jan; 136(2):389-95. PubMed ID: 2416806
[TBL] [Abstract][Full Text] [Related]
35. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
[TBL] [Abstract][Full Text] [Related]
36. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
37. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
38. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
Owens T; Fazekas de St Groth B
J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
[TBL] [Abstract][Full Text] [Related]
39. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
40. Arsonate-specific murine T cell clones. V. Antigen presentation by L cells transfected with normal and mutant class II genes.
Norton FL; Davis CB; Jones PP; Goodman JW
J Immunol; 1989 Jul; 143(2):446-51. PubMed ID: 2472438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
